[Anticoagulation's problematic during pregnancy in carriers of mechanical heart prosthesis].

Autor: Benatta NF; Faculté de médecine Oran, Oran, Algérie. Electronic address: benattanadia@yahoo.fr., Batouche DD; Faculté de médecine Oran, Oran, Algérie., Djazouli MA; Faculté de médecine Oran, Oran, Algérie.
Jazyk: francouzština
Zdroj: Annales de cardiologie et d'angeiologie [Ann Cardiol Angeiol (Paris)] 2018 Sep; Vol. 67 (4), pp. 270-273. Date of Electronic Publication: 2018 Jun 15.
DOI: 10.1016/j.ancard.2018.03.003
Abstrakt: Introduction: The heart prosthesis pregnant women are becoming more frequent due to the persistence of rheumatic fever in the country sends developments.
Objective: To propose management strategies from preconception to pregnancy and postpartum.
Materials and Methods: Prospective study from 2009-2014 about parturientes followed in cardiology and maternity on center Hospitalo University Oran.
Results: Thirty patients were followed, ejection fraction was equal to 60% in 29 cases. A single case of stenosis of the aortic prosthesis. Sixteen received low molecular weight heparins (LMWH) enoxaparine kind between 6 and 12 weeks, 13 received l'acenocoumarol (AVK) in the first quarter. One patient had been insufficient dose enoxaparine to 1/day and complicate ischemic stroke, abortion of a fetus of 16 weeks malformed in a mother who received acenoucoumarol (AVK) in the first quarter. Maternal mortality was null.
Discussion: LMWHs were 100% effective in sufficient doses, the VKA and LMWH relay period was critical and should be done in a hospital setting.
Conclusion: Wearing a prosthetic valve is compatible with supervised pregnancy LMWHs were 100% effective, provided they were used in sufficient doses between 6-12 weeks of amenorrhea.
(Copyright © 2018 Elsevier Masson SAS. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: